Curriculum Structure for Master of Science Program in SEAP |
(Revised program 2020) This program has been certified by AUN-QA until 2025 |
Program aim |
The program aims to produce a graduate who has social, economic and administrative competency in the context of Pharmacy and medication management context.
|
Program Policy |
- SEAP program has responsibility for supplying the healthcare scholar and manager for the society and the world.
- SEAP program can enroll a maximum of 10 students per academic year to assure the quality of graduate student.
- An applicant must have the potential to perform self-development according to the program objective and MU graduate attribute.
- An applicant should have an interesting issue to use as a thesis topic.
|
Program Learning Outcomes |
1. Ethics
1.1 Respect the principle of intellectual property rights.
1.2 Embrace ethics and professional ethics.
2. Knowledge
2.1 Understand, describe, define and explain the principle and method of public health, social sciences, and management related to drug and health systems.
2.2 Understand, describe, define and explain research techniques that are accepted in the development of drug and health systems.
3. Intellectual skill
3.1 Analyze the socio-economic and administrative issues related to drug and health systems.
3.2 Apply knowledge in the context of drug and health systems.
3.3 Design a research related to social pharmacy, economics and administration by using an appropriate research methodology.
4. Interpersonal skill and responsibility
4.1 Interact (persuade) properly with colleagues and stakeholders.
4.2 Enthusiastically work as a team member and demonstrate leadership attributes.
4.3 Perform and participate in socially responsible activities.
4.4 Have a responsibility in achieving an assignment.
5. Numerical analysis skills, communication, and information technology
5.1 Use IT to search, manage, analyze and present qualitative/ quantitative academic data.
|
Program objectives |
After completion their study, students will have characteristics, which comply with Thailand Quality Framework standard as follows:
- Have appropriate behavior and commit to upholding and embracing the highest ethical and professional standard in academic and practice.
- Possess knowledge in implementing policy. Provide evidence-based information for policy formulation, management, and administration, and be able to understand, describe, define and explain relevant knowledge related to economic and drug policy leading to an improvement in the drug and health systems.
- Be able to analyze, apply and design social science, economic, epidemiology and management research, which lead to the development of drug and health care systems.
- Have good human relation, social responsibility, and leadership skill.
- Have numerical analysis skills, and information technology skills, which can be applied for drug and health systems.
|
|
Job option after graduation |
- Expert in the area of Social, Economic and Administrative Pharmacy for undergraduate students.
- Drug and health system executives (both public and private sectors)
- Technical/academic officer for drug system and health system
- High caliber researchers in the field of drug and health system development
|
|
Strength of the program |
Our distinguished faculties include internationally and nationally renowned researchers who are actively engaged in international and national drug and vaccine policy.
|
|
Our programs also have strong research collaboration with many government organizations including |
- Food and Drug Administration (FDA)
- Health Intervention and Technology Assessment Program (HITAP)
- International Health Policy Program (IHPP)
- Health System Research Institute (HSRI)
- National Health Security Office (NHSO)
- National Vaccine Institute (NVI) World Health Organization (WHO)
|
|
Program structure |
Compulsory subject |
15 credits |
Elective subject, at least |
9 credits |
Thesis |
12 credits |
Total, at least |
36 credits |
|
|
Study plan |
Year |
First semester |
Second semester |
1 |
- GRID 603 Biostatistics 3(3-0-6)
- PYSP 671 Research Methodology in Social Science I 2(2-0-4)
- PYSP 674 Drug and Health System Management 2(2-0-4)
- PYSP 688 Seminar in Current Research on Social, Economic and Administrative Pharmacy 1(1-0-2)
- PYSP 675 Health Economic Evaluation 2(2-0-4)
- Elective courses 3 credits
Total 13 credits
|
- PYSP 676 Pharmacoepidemiology in Public Health 2(2-0-4)
- PYSP 710 Strategic Management in Health System 2(2-0-4)
- PYSP 690 Seminar in Research Methods on Social, Economic and Administrative Pharmacy 1(1-0-2)
- Elective courses 6 credits
Total 11 credits
|
2 |
- PYSP 698 Thesis 6(0-18-0)
Total 6 credits
|
- PYSP 698 Thesis 6(0-18-0)
Total 6 credits
|
Remark: Students have to pay for the field-trip study fee as part of PYSP 674 Drug and Health System Management.
|
|
Area of thesis research |
- Research in social sciences and humanities related to drug and health systems
- Pharmacoepidemiological studies
- Health outcomes research
- Cost analysis in health care
- Health economics and health technology assessment
- Drug and health system management at international, national, and hospital levels
- Drug and health policy analysis
- Analyzing, planning, and managing of health care personnel
- Strategic planning and organization management
- Development of tools and methodology for drug and health systems
- Health science study and research in subject areas include, but are not restricted to the following fields: heath related quality of life, hospital drug system, medication and patient safety, healthcare program evaluation, medicine use in community, priority setting in healthcare, medicine pricing, willingness-to-pay, hospital quality system, hospital accreditation and quality improvement, pharmacy education.
- Research on consumer protection and laws at national and international levels
|
|
Tuition fee |
Item |
Unit |
Cost/unit |
Quantity |
Cost (baht) |
US$ |
Check-in fee |
student |
3,000 |
1 |
3,000 |
100 |
Education service fee |
year |
10,000 |
2 |
20,000 |
667 |
Student Activities Fee |
semester |
250 |
4 |
1,000 |
34 |
Graduate Studies Fee |
semester |
750 |
4 |
3,000 |
100 |
Internet service fee |
semester |
300 |
4 |
1,200 |
40 |
Health insurance |
year |
3,500 |
2 |
7,000 |
234 |
Graduate tuition fee* |
credit |
9,000 |
24 |
216,000 |
7,200 |
Thesis registration fee |
thesis |
30,000 |
1 |
30,000 |
1,000 |
Research Supplies Fee |
student |
150,000 |
1 |
150,000 |
5,000 |
Work-site study fee |
student |
20,000 |
1 |
20,000 |
667 |
Total |
451,200 |
15,042 |
Exchange rate: 1 US$ = 30 Baht
Remark: Fees may be subject to change.
Thai students can apply for partial financial support (scholarship) on graduate tuition fee and research supply fee. |
|
The MSc Curriculum for Academic year 2020 and onwards
Required courses |
GRID 603 |
Biostatistics |
PYSP 671 |
Research Methodology in Social Science I |
PYSP 674 |
Drug and Health System Management |
PYSP 675 |
Health Economic Evaluation |
PYSP 676 |
Pharmacoepidemiology in Public Health |
PYSP 688 |
Seminar in Current Research on Social, Economic and Administrative Pharmacy |
PYSP 690 |
Seminar in Research Methods on Social, Economic and Administrative Pharmacy |
PYSP 710 |
Strategic Management in Health System |
PYSP 698 |
Thesis |
Elective courses |
PYSP 672 |
Social and Cultural Aspects Relating to Health |
PYSP 677 |
Health Outcome Assessment |
PYSP 678 |
Pharmaceutical Anthropology |
PYSP 679 |
Cost Analysis in Health Care |
PYSP 680 |
Hospital Pharmacy Administration and Practice |
PYSP 683 |
Cost-Effectiveness Modelling in Health |
PYSP 694 |
Cost-Effectiveness Analysis Using Clinical Trial and Observational Study |
PYSP 695 |
Evaluation of Pharmacy and Health Care Program |
Syllabus for Academic year 2020
Compulsory subject |
GRID 603 |
Biostatistics
Methods of statistical data collection, analysis and interpretation of biomedical and public health data; probability distributions; sampling distributions; estimation of parameters; significance tests by using parametric and nonparametric methods; analysis of variance; correlation and regression analyses
|
PYSP 671 |
Research Methodology in Social Sciences I
Knowledge and experiences in research methodology in social sciences which can be applied to pharmacy practice and system management; knowing various databases; performing systematic review and literature evaluation; research planning and design; sample size calculation; data collection; statistics for data analysis; research proposal writing; and ethics in reference citation and conducting the research
|
PYSP 674 |
Drug and Health System Management
Characteristics of drug and health system; concepts in drug system management; drug management cycle; drug system monitoring indicators; achievement and outcomes of drug system management at national and international levels
|
PYSP 675 |
Health Economic Evaluation
Principle health economics; cost analysis; principle and methods of health technology assessment and health economic evaluation; cost-effectiveness analysis; cost-utility analysis; cost-benefit analysis; budget impact analysis; quality assessment of studies on health economic evaluation; application of economic evaluation results in health care practice
|
PYSP 676 |
Pharmacoepidemiology in Public Health
Pattern of drug use; effects and safety of drugs in the large population; strengths and limitations of epidemiological methods; the strategies to prevent confounding and biases in pharmacoepidemiology studies; appropriate data analysis; sample size required for each study design; roles of pharmacoepidemiology in drug system as well as health care system
|
PYSP 688 |
Seminar in Current Research on Social, Economic and Administrative Pharmacy
Systematic review of current research on social, economic and administrative pharmacy; searching, collecting, analyzing, presenting the reviewed results
|
PYSP 690 |
Seminar in Research Methods on Social, Economic and Administrative Pharmacy
Method on systematic review in research methods on social, economic and administrative pharmacy; searching; collecting, analyzing, presenting the reviewed results
|
PYSP 710 |
Strategic Management in Health System
Strategic management in health system; definition of strategy; components of strategic plan; internal and external environment analysis; strategy implementation; controlling; monitoring; evaluating of strategic plan; tools in strategic management in health system to take strategic advantage, cost effectiveness and sustainability of health organizations
|
Elective Subject |
PYSP 672 |
Social and Cultural Aspects relating to Health
Basic concepts and theories regarding culture and cultural anthropology; meaning and significance of health, symptoms, illness and healing; concepts concerning medical pluralism; strategies of biomedical culture in achieving mainstream medicine; political economy concepts focusing on unequal power relations among various groups; unequal accessibility to health and health services
|
PYSP 677 |
Health Outcome Assessment
Theory and concept about outcome evaluation; types of health outcome; development of instrument for health outcome evaluation; psychometric properties of the instrument; evaluation of instrument used in health outcome measure; method used in health outcome assessment
|
PYSP 678 |
Pharmaceutical Anthropology
Basic concepts and theories relating medical anthropology emphasizing on Health; Illness; Medicine and medical technology utilization; Meaning and significance of Self-medication; Herbal medicine and Modern medicine; Hidden ideology of pharmaceutical and medical technology industries; Unequal accessibility to medicine and medical technology; Repercussions of medicine and medical technology; patient adherence; patient self-surveillance and re-definition of life
|
PYSP 679 |
Cost Analysis in Health Care
Principle and methods of costing for both theory and practice of unit cost of medical services; health care program and cost of illness; Study design; data collection; analysis result presentation and use of costing information for management
|
PYSP 680 |
Hospital Pharmacy Administration and Practice
Theories and analyses relating to planning; human resource management and quality assurance; drug distribution system; pharmaceutical epidemiology; financial and budgeting system; purchasing and inventory control; manufacturing management; management of information system and training in the hospital
|
PYSP 683 |
Cost-Effectiveness Modelling in Health
Cost and effectiveness measurement in cost-effectiveness modeling; meta-analysis; medical statistics related to survival analysis; decision tree model and Markov model development; use of discounting rate and uncertainty analysis; probabilistic modeling; result presentation from probabilistic model; budget impact analysis; issues of ethics, equity or feasibility
|
PYSP 694 |
Cost-Effectiveness Analysis Using Clinical Trials and Observational Studies
Study design of clinical trial; design and collection costing data; merging of clinical data and costing data; cost-effectiveness analysis from clinical trial data and additional costing data; Management of data from patient database; manipulating outcome variables; calculating treatment cost; differentiating magnitude of outcomes caused by intervention and confounders by various methods; cost-effectiveness analysis from cost and outcome after adjusting effect of confounders |
PYSP 695 |
Evaluation of Pharmacy and Health Care Program
Purposes and concepts of evaluation; understanding pharmacy and health care program; roles for the evaluator; basic issues of evaluation design, data collection, interpretation, and communication of results; ethics of an evaluation studies |
Thesis |
PYSP 698 |
Thesis
Identifying research proposal; Conducting research with concern of research ethics; Data collection; analysis; interpretation of the result and report the result in terms of thesis; Presenting and Publishing research in standard journals or a conference’s proceedings; Ethics in dissemination of the research results |
|